Contribution of the addition of anti-ββ2-glycoprotein to the classification of antiphospholipid syndrome in predicting adverse pregnancy outcome

被引:5
作者
Oron, Galia [4 ]
Ben-Haroush, Avi [1 ,4 ]
Goldfarb, Rachel [4 ]
Molad, Yair [2 ,4 ]
Hod, Moshe [4 ]
Bar, Jacob [3 ,4 ]
机构
[1] Helen Schneider Hosp Women, Rabin Med Ctr, Perinatal Div, IL-49100 Petah Tiqwa, Israel
[2] Rabin Med Ctr, Rheumatol Unit, Lupus Clin, Petah Tiqwa, Israel
[3] Wolfson Med Ctr, Perinatal Div, Holon, Israel
[4] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
Anti-beta; 2; glycoprotein; 1; antiphospholipid syndrome; pregnancy; complications; INTERNATIONAL CONSENSUS STATEMENT; SYSTEMIC-LUPUS-ERYTHEMATOSUS; EUROPEAN-FORUM; ANTIBODIES; CRITERIA; RISK; ANTI-BETA(2)-GLYCOPROTEIN-I; AUTOANTIBODIES; ASSOCIATION; UPDATE;
D O I
10.3109/14767058.2010.511339
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Methods. aEuro integral A retrospective cohort design was used. Ninety-one patients (total 394 pregnancies) referred to a tertiary medical center for evaluation of clinical features consistent with APS were divided into three groups: group A (n == 34), two positive tests for anticardiolipin (ACL) or lupus anticoagulant (LAC), in accordance with original APS classification (1998); group B (n == 18), two positive tests for a-beta beta 2GP1, in accordance with the revised APS criteria; and group C (n == 39), only one positive test for ACL or LAC. Results. aEuro integral Of the 52 women with APS (group A or B), 36 had primary disease, and 16 had secondary disease. On comparison of the groups, group B was characterized by a significantly higher rate of complicated pregnancy (83.3%%) than groups A (47.1%%) and C (76.9%%), P == 0.007, and a higher rate of fetal loss (72.2%%) than groups A ++ C (28.8%%, P == 0.001). Conclusions. aEuro integral The findings suggest that the revised APS criteria are preferable to the original classification for the prediction of complicated pregnancy.
引用
收藏
页码:606 / 609
页数:4
相关论文
共 50 条
  • [1] Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome
    Mondejar, R.
    Gonzalez-Rodriguez, C.
    Toyos-Saenz de Miera, F. J.
    Melguizo-Madrid, E.
    Zohoury, N.
    Mahler, M.
    Romero Losquino, I.
    Fabiani, F.
    CLINICA CHIMICA ACTA, 2014, 431 : 174 - 178
  • [2] Anti-β2-glycoprotein I antibodies and the antiphospholipid syndrome
    Li, Z
    Krilis, SA
    AUTOIMMUNITY REVIEWS, 2003, 2 (05) : 229 - 234
  • [3] Anti-ß2 glycoprotein I antibodies and pregnancy outcome in antiphospholipid syndrome
    Liu, Xin Li
    Xiao, Jing
    Zhu, Fufan
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2013, 92 (02) : 234 - 237
  • [4] Avidity of anti-β2-glycoprotein I and thrombosis or pregnancy loss in patients with antiphospholipid syndrome
    Cucnik, S
    Bozic, B
    Kveder, T
    Tomsic, M
    Rozman, B
    AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS, 2005, 1051 : 141 - 147
  • [5] Avidity of anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome
    Cucnik, S.
    Kveder, T.
    Artenjak, A.
    Gallova, Z. Ulcova
    Swadzba, J.
    Musial, J.
    Iwaniec, T.
    Stojanovich, L.
    Alessandri, C.
    Valesini, G.
    Avcin, T.
    Tervaert, J. W. Cohen
    Rozman, B.
    Bozic, B.
    LUPUS, 2012, 21 (07) : 764 - 765
  • [6] Value of Isolated IgA Anti-β2-Glycoprotein I Positivity in the Diagnosis of the Antiphospholipid Syndrome
    Murthy, Vijaya
    Willis, Rohan
    Romay-Penabad, Zurina
    Ruiz-Limon, Patricia
    Martinez-Martinez, Laura A.
    Jatwani, Shraddha
    Jajoria, Praveen
    Seif, Alan
    Alarcon, Graciela S.
    Papalardo, Elizabeth
    Liu, Jigna
    Vila, Luis M.
    McGwin, Gerald, Jr.
    McNearney, Terry A.
    Maganti, Rashmi
    Sunkureddi, Prashanth
    Parekh, Trisha
    Tarantino, Michael
    Akhter, Ehtisham
    Fang, Hong
    Gonzalez, Emilio B.
    Binder, Walter R.
    Norman, Gary L.
    Shums, Zakera
    Teodorescu, Marius
    Reveille, John D.
    Petri, Michelle
    Pierangeli, Silvia S.
    ARTHRITIS AND RHEUMATISM, 2013, 65 (12): : 3186 - 3193
  • [7] Anti-β2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome
    Hanly, JG
    Smith, SA
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (09) : 2152 - 2159
  • [8] Anti-β2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome
    Lopez, LR
    Dier, KJ
    Lopez, D
    Merrill, JT
    Fink, CA
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 121 (01) : 142 - 149
  • [9] The avidity of anti-β2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies
    Cucnik, S.
    Kveder, T.
    Ulcova, G. Z.
    Swadzba, J.
    Musial, J.
    Valesini, G.
    Avcin, T.
    Rozman, B.
    Bozic, B.
    LUPUS, 2011, 20 (11) : 1166 - 1171
  • [10] Combined detection of anticardiolipin and anti-β2-glycoprotein 1 antibodies may predict pregnancy outcome
    Yang, Rongjuan
    Zhang, Jiajia
    Zhang, Limei
    Liu, Yongli
    Guo, Qing
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (03): : 1750 - 1756